ARCL Organics Q2 FY27 standalone: Revenue Rs 83.04 cr, PAT Rs 5.73 cr
Results$ARCL

ARCL Organics Q2 FY27 standalone: Revenue Rs 83.04 cr, PAT Rs 5.73 cr

For the quarter ended 30-Sep-2026, ARCL Organics’ standalone revenue from operations was Rs 83.04 cr and PAT Rs 5.73 cr versus Rs 86.19 cr and Rs 7.08 cr a year earlier.

ARCL Organics Ltd
ARCL Organics LtdReviewed and published by · How we report
2 min read
arcl organicsq2 fy27quarterly resultsstandalonechemicals
ShareWhatsAppXLinkedIn

Key takeaways

  • Revenue from operations Rs 83.04 cr vs Rs 86.19 cr a year earlier
  • PAT Rs 5.73 cr for Q2 FY27 vs Rs 7.08 cr in Q2 FY26
  • Total income Rs 84.13 cr vs Rs 87.37 cr in the year-ago quarter
  • Total expenses Rs 74.67 cr vs Rs 74.80 cr a year earlier
  • EPS (basic and diluted) Rs 7.16 vs Rs 8.85 in the corresponding quarter

Q2 FY27 · standalone

MetricSep 2026Sep 2025Change
RevenueRs 83.04 crRs 86.19 cr-3.7%
PATRs 5.73 crRs 7.08 cr-19.0%

As reported in the filing. Figures are transcribed, not computed.

ARCL Organics Ltd's next results reach Pro the minute they're filed.Try Pro free for 14 days

What the numbers show

  • Net margin was 6.90% of revenue, down 131 bps from 8.21%.
  • Total expenses fell 0.2% while revenue fell 3.7%.
  • Cost of materials took 88.0% of revenue, against 54.5% a year earlier.

Key numbers (standalone, Q2 FY27 vs Q2 FY26)

All figures are from the statement of un-audited standalone financial results for the quarter ended 30-Sep-2026 and the corresponding quarter ended 30-Sep-2025.

  • Revenue from operations: Rs 83.04 cr (Q2 FY27) vs Rs 86.19 cr (Q2 FY26)
  • Other income: Rs 1.10 cr vs Rs 1.18 cr
  • Total income: Rs 84.13 cr vs Rs 87.37 cr
  • Cost of materials consumed: Rs 73.11 cr vs Rs 47.00 cr
  • Purchase of stock in trade: Rs - vs Rs 17.15 cr
  • Changes in inventories of Finished Goods, Work-in-Progress and Stock-in-Trade: Rs -17.76 cr vs Rs -4.03 cr
  • Employee benefits expense: Rs 4.30 cr vs Rs 3.37 cr
  • Other expenses: Rs 15.01 cr vs Rs 11.32 cr
  • Total expenses: Rs 74.67 cr vs Rs 74.80 cr
  • Earnings before Finance costs, Depreciation & Amortisation, Exceptional Item and Tax (EBITDA): Rs 9.46 cr vs Rs 12.57 cr
  • Finance costs: Rs 1.44 cr vs Rs 0.9866 cr
  • Profit after Finance costs but before Depreciation & Amortisation, Exceptional Item and Tax: Rs 8.03 cr vs Rs 11.58 cr
  • Depreciation and amortisation expenses: Rs 2.16 cr vs Rs 1.49 cr
  • Profit before tax (PBT): Rs 5.87 cr vs Rs 10.09 cr
  • Net tax expense / (benefit): Rs 0.14 cr vs Rs 3.01 cr
  • Profit after tax (PAT): Rs 5.73 cr vs Rs 7.08 cr
  • Other comprehensive income: Rs -0.217 cr vs Rs -0.0938 cr
  • Total comprehensive income: Rs 5.51 cr vs Rs 6.99 cr
  • Paid up equity share capital: Rs 8.00 cr vs Rs 8.00 cr
  • Earnings per share – basic: Rs 7.16 vs Rs 8.85
  • Earnings per share – diluted: Rs 7.16 vs Rs 8.85

For the half year ended 30-Sep-2026, standalone revenue from operations was Rs 149.98 cr and PAT Rs 14.64 cr, compared with revenue from operations of Rs 153.53 cr and PAT of Rs 10.89 cr for the half year ended 30-Sep-2025, as per the same statement of financial results.

The board’s outcome letter also notes that the Board of Directors, at its meeting held on 12th November, 2026, declared the 1st Interim Dividend of Rs 1 per equity share of face value of Rs 10 each for the Financial Year 2026-27, with Wednesday, 18th November, 2026 as the Record Date and payment to be made on or before 12th December, 2026, as stated in the notes to the statement of financial results and the board’s outcome communication.

Get ARCL Organics Ltd's next results the minute they're filed

Results reach the exchange at all hours, most of them after the market closes. Pro puts the filing in your feed as it is published, with our read of the numbers. A free account sees it an hourback for a day.

  • We'll start you off following ARCL.
  • 14 days free, no card. After that you keep a free account.

Get every filing that moves a stock

One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.

Cruxal publishes market coverage for information only. Nothing here is investment advice.